Actively Recruiting
Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
Led by Seattle Children's Hospital · Updated on 2024-04-19
2000
Participants Needed
2
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
CONDITIONS
Official Title
Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Single placenta (Monochorionic)
- Polyhydramnios in recipient twin (more than 8 cm max vertical pocket before 20 weeks or more than 10 cm after 20 weeks gestation)
- Oligohydramnios in donor twin (less than 2 cm max vertical pocket)
- Prominent bladder in recipient twin and non-filling bladder in donor twin
- Thin dividing membrane between twins
You will not qualify if you...
- Unwillingness to participate or follow up
- Major congenital anomalies incompatible with survival
- Active pre-term labor or ruptured membranes
- Chorioamnionitis
- Vaginal bleeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Seattle Childrens Hospital
Seattle, Washington, United States, 98015
Actively Recruiting
2
University of Washington
Seattle, Washington, United States, 98195
Active, Not Recruiting
Research Team
M
Martin P Walker, MD
CONTACT
M
Melissa Dorn, RN MN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here